Počet záznamov: 1
imipeném
SYS d015378 LBL 00000nz--a2200000o--4500 005 20250606214705.0 008 920603|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.065.589.099.124.300.500 065 $a D03.633.100.300.124.300.500 066 $a 01 $c 03 150 $a imipeném $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Imipemide $2 eng 450 $w v $a N-Formimidoylthienamycin $2 eng 550 $7 sllk_us_auth*d000900 $Y Anti-Bacterial Agents $w P $a antibiotiká 665 $a 89 $2 eng 665 $a Antibiotics (1980-1982) $2 eng 665 $a Thienamycins (1983-1988) $2 eng 680 9-
$i Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor. $2 eng 750 -2
$a Imipenem $2 eng 980 $x M
Počet záznamov: 1